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Summary: We describe the construction, the reaction principle and the performance of Reflotron® K+, a new
Reflotron® test for the quantitative determination of potassium in serum and heparinized plasma.
The reaction principle is based on the introduction of the potassium cation via valinomycin into a non-polar
phase; the accompanying loss of protons from the non-polar phase is detected by the colour change of a pH
indicator.
The multicentre evaluation of the reagent carrier system showed in median CVs of < 0.9% (within-series in
heparinized plasmas) and 1.3% (run-to-run in control sera).
The recovery in control sera was ± 4% for seven laboratories.
In the method comparison with flame emission spectrometry, using sera and heparinized plasma samples,
regression analysis yielded correlations with slopes of 1.00 + 0.04 (median slope 1.005) and negligible
intercepts.
The reagent carrier system showed a linear response in the measuring range 2—12 mmol/1.
Bilirubin (up to 513 μιηοΐ/ΐ), triacylglycerols (up to 5,7 mmol/1), sodium (135 — 189 mmol/1) and ammonium
ions (up to 590 μιηοΐ/ΐ) did not interfere with the test.
Comparison with the results from flame atomic emission spectrometry shows that the recoveries of Reflo-
tron® K"1" and the direct potentiometric method are slightly and similarly influenced by total protein.
With a panel of 28 drugs tested, no interference could be detected.
Reflotron® K+ provides a precise and reliable procedure for the measurement of potassium in serum and
heparinized plasma.
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Introduction
The determination of potassium in serum or plasma
is important in emergency cases and for monitoring
dyskalaemia and its therapy. Both hyperkalaemia or
hypokalaemia, if severe, are dangerous, and must be
treated immediately.
The commonly used methods for the determination
of potassium concentrations are flame atomic emis-
sion spectrometry (FAES) and potentiometric meas-
urements with ion selective electrodes (ISE). The rel-
atively expensive instruments required are standard
equipment in every clinical laboratory, but not in the
physician's office. The laboratories are, however, fre-
quently too far away from the office to perform
potassium determinations in emergency situations. To
allow simple, reliable, and quick potassium determi-
nations in the physician's office a test based on dry
reagent carrier technology was developed (1).
The recently developed dry reagent carrier Reflotron®
K4" employs a new technology for potassium deter-
mination by using a valinomycin-coupled colour re-
action. It completes the analyte menu of the Reflo-
tron® system for the quantitative analysis of clinico-
chemical analytes in undiluted samples.
The basic chemical reaction and the construction of
the dry reagent carrier of the new test are described
here together with the results of a multicentre evalu-
ation.
Test Principle of Reflotron® K+ and Structure of the
Reagent Carrier
The structure of the Reflotron® K+ reagent carrier is
shown in figure 1.
For potassium determination with Reflotron® K+,
30 μΐ of sample are applied to the yellow protective
Protective mesh
Indicator film
Magnetic code
Separating layer
Transport layer
* Carrier foil
mesh. The sample is then transported via two different
glass fibre layers (the separating layer and the trans-
port layer) to the reaction zone below the hinged part.
All the reagents necessary for detecting potassium are
contained in this reaction zone (indicator film).
All chemical reactions take place in this reaction film
in a combination of a non-polar/water-insoluble
phase and an aqueous phase.
The non-polar phase contains valinomycin as a po-
tassium carrier, a pH indicator and an organic acid
(nitronaphthol derivative) (fig, 2).
The potassium cation [K+] is introduced via valino-
mycin into the non-polar phase where it is specifically
bound as a charged complex. As a result of the change
in charge, ion exchange takes place and the pH in-
dicator releases a proton [H+] to the aqueous plasma/
serum phase. The organic acid may also release a
proton, thus forming a colourless anion to compete
with the indicator and to optimize the intensity of the
colour formed (fig. 3).
Indicator
PC18H37
4-[(2,6-Dibrom-4-nitrophenyl)azo]-2-octadecyloxy-1-naphthol
Acid
O2N
H37CI8O NO2
2, 4, 6, 8-Tetranitro-5-octadecyloxy-1-naphthol
Fig. 1. Structure of the Reflotron® K+ reagent carrier.
Fig. 2. Structure of the pH indicator and the organic acid
(nitronaphthol derivative) used in the test principle of
Reflotron® K+.
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Non-polar phase Aqueous phase Non-polar phase Aqueous phase
Val (VahK)* Γ
I-H K* ^ or H*
A-H (Val-K)+ A-
Val: valinomycin
I-H: indicator acid
Γ: indicator anion
K+: potassium ion
A-H: acid
A": acid anion
Fig. 3. Test principle of Reflotron® K+.
0 2 4 6 8 1 0
Fig. 4. Calibration curve of Reflotron® K+.
12 14
K+ [mmol/l]
The intensity of the colour change of the pH indicator
is proportional to the potassium concentration in the
sample. It is measured by reflectance photometry at
642 nm and the result is displayed after approximately
150s.
It is well known that haemolysis, or considerable
admixture of potassium due to damage to tissue cells
during capillary blood collection, can lead to falsely
elevated potassium values. To avoid this, the use of
venous serum or heparinized plasma as sample ma-
terial is recommended.
Reflotron® K+ was calibrated against the FAES (see
fig. 4 for calibration curve) using the same procedure
as with the other Reflotrpn® tests (2, 3). The calibra-
tors were prepared from serum and checked for nor-
mal protein content (about 70 g/1). The sample ma-
terial was shock-frozen and stored at —20 °C.
In each laboratory, lithium heparinate-treated plasma samples
of 5 concentration ranges were measured within-series in tenfold
determinations with the reagent carriers and various compari-
son methods in the framework of the imprecision study. The
median, minimum and maximum imprecisions were determined
for each concentration range and each comparison method.
The run-to-run imprecision was measured in 14 to 82 runs at
each laboratory using control sera Precinorm1* U and Preci-
path® U for Reflotron®. Both control sera also served for the
daily quality control of the reagent carrier system and the
comparison methods.
The accuracy of Reflolron^ K+ was ascertained by method
comparisons with scrum and heparinized plasma samples. For
this purpose, the same control sera (Refiotron'* Precinorm'* U,
Reflotron® Precipath^ U) were included in the runs at the 7
evaluation sites. The target values for Reflotron^ K+ were
determined by Boehringer Mannheim prior to the study, using
different instruments. For the ISE methods, an orienting value
ascertained in 2 laboratories (Laboratory 1 and Boehringer
Mannheim Evaluation Diagnostics) was used instead of a target
value. For flame photometry, preliminary target values were
used which were later replaced by the values obtained with the
official reference method of the German Society for Clinical
Chemistry (6).
In the method comparison experiments, K.+ was determined in
serum and heparinized plasma samples (81—260 samples per
site), using Refiotron® K+ and the various comparison methods
(tab. 3). The regression analysis was performed according to
the recommendations of Passing & Bahlok (7, 8).
The linearity of the reagent carrier system was checked by
analysing samples at 11 different concentrations. These were
obtained by mixing different aliquots of two plasmas with
potassium concentrations of 11.38 mmol/l and 2.51 mmol/l
respectively.
The interference study for the detection of potential interferents
was performed at evaluation site 8 relative to FAES (IL 953,
Instrumentation Laboratory) using heparinized plasma sam-
ples.
The relative bias between Reflotron® K+ and FAES for differ-
ent interferents was calculated.
Endogenous substances
a) 44 plasmas containing bilirubin between 8 and 560 μπιοΐ/ΐ,
b) 35 plasmas containing triacylglycerols between 0.8 and 6.2
mmol/l,
c) heparinized plasmas with added sodium and ammonium
ions.
The protein dependence of the performance of the reagent
carrier method and the ISE method (ISE 2020 analyser, Boeh-
ringer Mannheim) relative to FAES was examined using 78
sera with protein concentrations between 28.8 and 130.7 g/1.
The protein concentration was determined by the biuret reac-
tion (9). The protein dependence was assessed by regression
analysis of
Materials and Methods
A basic description of the Reflptron® instrument has been given
previously (3, 4).
The analytical performance of Reflotron® K+ was examined in
a raulticentre evaluation at seven sites following the same pro-
tocol (5).
[K+]FAES
(relative method differences in %)
χ 100%
versus total protein concentration. The same procedure was
used- for the protein dependence of the ISE method (ISE 2020
analyser).
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Exogenous influences
Therapeutic and toxic concentrations of 28 commonly used
drugs were tested for interference with the Reflotron® K+
reagent carrier (10).
Results and Discussion
Imprecis ion study
The results of the within-run imprecision study using
plasma samples treated with lithium heparinate are
summarized in table 1.
The minimum, median and maximum coefficients of
variation obtained for Reflotron® K* and the com-
parison methods are specified for five concentration
ranges.
The Reflotron® K+ performed well, showing a median
CV of < 0.9%'in all five concentration ranges. The
median CV obtained for FAES is even better (CV
< 0.5%), while the ISE methods yielded a CV of
< 1.0%, which is comparable to that of Reflotron®
K+.
The run-to-run imprecision of Reflotron® K+ was
determined with the lyophilized control materials,
Precinorm® U and Precipath® U for Reflotron®. The
median CVs obtained for Reflotron® K+, FAES and
the ISE methods are very similar (tab. 2), indicating
a very good performance of the new dry chemistry
system, Reflotron® K+.
These results show that the reagent carrier system
clearly fulfills the requirements with respect to ana-
lytical precision (CV < 2.4%) (6,11).
Measuring range
The results of the linearity experiment are illustrated
in figure 5. The maximum deviation from the regres-
sion line of the values measured with Reflotron® K+
for the 11 aliquots (with potassium concentrations
from 2.51 to 11.38 mmol/1) was less than 1.9%.
12
 r
2 4 6 8 1 0
Target value (calculated) [mmol/l]
Fig. 5. Linearity of Reflotron® K+.
y = -0.006 + l.OOx
This experiment verifies the linearity of the reagent
carrier system in the measuring range from 2-^12
mmol/1 claimed by the manufacturer.
Accuracy of K+ assay in control sera
Table 2 shows that the recovery of the target values
in control sera with Reflotron® K+ in the 7 labora-
tories was approx. 101% (100 ± 4%), while a 100%
recovery was obtained for the reference method value
of flame photometry (100 + 2%) and the orienting
value of the ISE methods (100 ± 6%). The excellent
recovery of the reference method value for flame
photometry is a prerequisite for the assessment of the
results from the method comparisons.
It has to be mentioned that there are marked differ-
ences (5—7%) in the target values for the reagent
carrier system and FAES. As shown below, control
sera and original human sample material obviously
behave differently in the reagent carrier system and
the FAES method.
Tab. 1. Within-run imprecision of Reflotron® K+ using plasma samples treated with lithium heparinate (n = 10).
Concentration Number
range
[mmol/1]
2.6-3.0
3.0-4.0
4.0-5.0
5.0-6.0
6.0-6.8
of
samples
3
10
5
5
5
CV [% ] CV [%]
Reflotron® K+
min
0.7
0.6
0.4
0.3
0.4
median
0.9
0.8
0.8
0.7
0.5
max
1.2
1.4
2.6
1.2
0.5
FAES
min
0.3
0.2
0.2
0.2
0.1
median
0.5
0.5
0.4
0.3
0.3
cv r%i
ISE methods
max
1.2
1.1
0.4
0.4
1.0
min
0.7
0
o ;
0.2 "
0.5
median
1.0
0.8
0.4
0.5
0.5
max
1.1
1.1
0.7
1.1
0.7
Eur. J. Clin. Chem. Clin. Biochem. / Vol. 31,1993 / No. 8
Paschen et al.: Determination of K+ by dry reagent carrier 549
es
CO
ONξ
£
£DΦ
·£«
S,2*ι
§
sp
·*_·
ρ-
' ®
Ο
Ι
οο ΕΙΓ
If 1
S w .S.4} "^"^
s ffs22 ,2 so
_
— ΞΞ-11
ω W °*
U, ,2 SO
+
<u ^»
& 3 "o
o "3 S
£ Ξ SO o 'C2 oX)oo
'S 0 §
o g'o
pq £?g°,
22 S ί/S
M
"S "3"
•2 c
> έ
III
PH -2 W"5
+
β ° ^ "
1 s 1
0 «Α
'S £3
P< .2 wS
^- 1O M
Ί
 ctS 'S -S
2^
>"
U^L
g
oε
IX JL
a^1
>^r
O^l
CT
"ej|
IX iH.
II
>TO -° ·
-^,
s*
o
,χί
«g ι ·
s£
ξ> g
• 1
,«1
c ""^ ^
sfc.
>"
o ^
***.
'S
ix JE·
S Γ7
S^.
>^U 2=u
"^o7*
IX £
t— »-i ON CO i-« CO O
CO so co Ο Ο co O
+ I + + I I
~ Ο Ό i-i SO ~-ι Ο
es es ι-ί es es
so r*- co ON ^H
ON CO ON t**^  t**^  ^ t**^
so so so so so SO so
p CO TT so Ο vo
1 i-3 es" 1-3
1 i l l
r*, oo r·» vo -^ w^
^ o 1 i^ es ^-3
S es co r- r-·vo r^ χί; u-> so
so so 1 so so so so
es ·*-» es so o ON ON
-^ o es* i-3
+ 1 1 1 + + +
ir> co so es— ^ ;^ so
τ-« ι— ι ο ·»— ' ·»— · co es
o\ es r*- ^ *-* ^t
CO *H CO CO »0 rf WO
so so so so so so so
es so r·* wo co ON co
rj-' so f-i es"
+ 1 + + + 1 +
so ο ττ o ^ i^ «n
*-! es -^' ^ es es
es oo i-· i-«p ^ oo oo oo so oo
so wo wS wS wS uS wS
oo TT ^ TJ- ^r
• -r* o 1 es * o ^
1 °
•^ - ^ ON es so
^ ·^ 1 ~· 1-3 <s
r**· ON ON ON ON
t-s. so r^ »o vo c*^
iri uS ' wo wS wS wn
TH ON w-j wo c·^  -^ ; t^
es i-3 TTH -«-ι co es" co
+ ι + -κ + + +
es c^ so es p p Tf
v4 i-3 o ^ i-3 co co
Γ> so ^J ^ so ON so
wS wS vi wo wo wi wS
oo ^- oo es> i-· es ^ti-i ι-· τ-· oo co es ι-»
i-< es co Tf wo so r-*
1
£
11
2
§
0
1
Ί
"X
ο
flj
^A
„
Accuracy of K+ assay in sera and heparin
plasmas
The results of the method comparison experiments of
seven laboratories are summarized in table 3. Most
laboratories measured serum or heparin-treated
plasma samples with the reagent carrier system and
3 4 5 6 7
Potassium (IL 943) [mmol/l]
10
Fig. 6. Comparison of Reflotron® K+ and FAES (IL 943) for
the determination of serum K+;
regression data:
y = -0.0497 + l.Olx; r = 0.992; n = 260.
3 4 5 6 7 8
Potassium (Stat KNA 2) [mmol/l]
10
Fig. 7. Comparison of Reflotron® K+ and ISE method (Nova
Stat KNA 2) for the determination of K* in hcparinized
venous plasma;
regression data:
y = -0.220 + 1.05x; r = 0.993; n = 168.
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Tab. 3. Comparison Reflotron^ K+ versus FAES and ISE methods.
Evaluation
site
1
2
3
4
5
6
7
Sample
serum
serum
serum
plasma
plasma
plasma
plasma
plasma
serum
serum
serum
serum
plasma
plasma
plasma
plasma
• \
plasma
plasma
plasma
plasma
plasma
No. of
samples
260
260
260
111
111
111
91
91
144
144
210
210
201
201
223
225
168
168
81
200
200
Comparison method
FAES (IL 943)
ISE (AVL 982-S)
ISE (Hitachi 717)
FAES (IL 943)
ISE (AVL 982-S)
ISE (Hitachi 717)
FAES (IL 943)
ISE (IL 501)
ISE (ISE 2020)
ISE (Hitachi 737)
FAES (IL 943)
ISE (Nova I)
FAES (IL 943)
ISE (Nova I)
FAES (Eppendorf 6341)
ISE (Beckman Astra 8)
FAES
ISE (Nova Stat KNA 2)
ISE (Beckman CX3)
FAES (IL 943)
ISE (Beckman CX3)
Concentration
range
[mmol/1]
2.2- 9.8
2.3-10.2
2.0- 9.3
3.0- 6.4
3.2- 7.0
3.2- 6.8
3.2- 6.5
2.8- 6.4
2.8- 6.4
2.8- 6.2
2.6- 6.6
2.6- 6.6
2.7- 7.8
2.7- 7.8
2.1- 9.5
2.2-10.9
3.0- 9.0
3.0- 8.7
3.0- 5.8
2.4- 6.9
2.4- 7.2
Slope
1.011
0.925
1.062
1.000
0.904
1.000
0.972
0.992
0.947
1.019
0.975
0.987
0.980
0.973
1.041
1.011
1.043
1.050
0.976
1.040
0.991
Intercept
[mmol/1]
• f
-0.05
+0.09
-0.24
+0.03
+ 0.25
-0.12
+0.02
+0.04
+0.03
-0.11
-0.02
-0.08
-0.03
0.00
-0.06
-0.06
-0.19
-0.22
-0.09
-0.16
+0.02
Coefficient
of
correlation
0.992
0.980
0.929
0.969
0.975
0.944
0.991
0.984
0.989
0.990
0.961
0.964
0.992
0.995
0.993
0.990
0.984
0.993
0.938
0.982
0.990
two comparison methods, i. e. flame atomic emission
spectrometry and the direct ISE method. Two method
comparisons are shown in figures 6 (versus FAES)
and 7 (versus ISE).
In the method comparison with FAES, the slopes of
the regression lines ranged between 0.972 and 1.043
(median slope 1.005). The intercepts were in most
cases negligible (range - 0.06 to + 0.03 mmol/1) with
two exceptions, at sites 6 and 7, of — 0.19 and — 0.16
mmol/1. In both cases a slope of 1.04 was partly
counterbalanced by the negative intercept.
In the method comparisons versus the direct ISE
method, the slopes of the regression lines were some-
what less close, ranging between 0.904 and 1.050
(median slope 0.987). These results reflect the trend
seen in the recoveries of the ISE methods with control
sera.
Thus, the results obtained with the reagent carrier
system and with the FAES method show excellent
comparability. The same is true for the comparison
with the direct ISE method, especially since three sites
used a slightly biased ISE comparison method.
The method comparison, Reflotron® K"1" versus
FAES, is based on the analysis of 1464 human sam-
ples. As a criterion for agreement between the two
methods for individual samples, a relative bias of 8%
was chosen according to 1. c. (11, 12), i.e. the maxi-
mum prescribed deviation between the value meas-
ured under routine conditions and the target value
(measured by reference method) is 8%. Of 1464 sam-
ples measured, only 4.2% were biased by more than
8% relative to the FAES results.
Taking into account that the FAES results in this
study are assessed under routine conditions with a
bias of their own and not by means of a reference
method, the results of the Reflotron® K+ and FAES
show good agreement. The Reflotron® K"1" is therefore
suitable for use in the doctor's office, particularly for
emergency situations.
The method comparison with the direct ISE method
is based on the results of 1095 samples, after excluding
the results of two laboratories with a systematic bias
of > 5%. It is interesting that only 2.1% of the
samples yielded a bias of > 8% between the two
methods. The reagent carrier system and the direct
ISE methods obviously show a higher degree of agree-
ment for individual samples, which is also reflected
in the protein dependence study (see below). One
reason is perhaps the use of valinoihycin in both
methods.
Interference study
* >
Using native human material, no interference could
be detected by bilirubin up to 513 μπιοΐ/ΐ, or triacyl-
Eur. J. Clin. Chem, Clin. Biochem. / Vol. 31,1993 / No. 8
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Tab. 4. Interference study on Rcflotron® K+ .
Constituent,
condition
Bilirubin
Triacylglycerols
NH4+
Na+
Sample volume
applied
glycerols up to
/ x_ ' l A\(tab. 4).
Interference by
Concentration
8 μιηοΐ/ΐ
17μπκ>1/1
85 μπιοΐ/l
170μηιο1/1
342 μηιοΐ/l
513μιηοΙ/1
1.1 mmol/l
2.3 mmol/l
3.4 mmol/l
5.7 mmol/l
29 μηιοΐ/l
590 μηιοΐ/l
135 mmol/l
140mmol/I
155 mmol/l
173 mmol/l
189 mmol/l
26 μΐ
28 μΐ
30 μΐ
32 μΐ
34 μΐ
Recovery
98%
99%
100%
100%
100%
103%
98%
100%
100%
100%
100%
99%
100%
100%
99%
101%
103%
90%
100%
100%
101%
102%
the maximum concentrations tested
sodium was investigated by supple-
Tab. 5. Drug interference
List of drugs and
study.
Drug
Acetylsalicylic acid
Ampicillin
Ascorbic acid
Bezafibrat
Carbochromen
Cephalosporin
Chloramphen icol
Caffeine
Cyclosporin
Dobesilatc (Ca)
Dopamine
Furosemid
Glibenclamid
Indomethacin
Methyldopa
Nicotinic acid
Nitrofurantoin
Oxytetracycline
Paracetamol
Phenprocoumon
Phenytoin
Probenecid
Procaine
Pyridamol (Di)
Quinidine
Sulfamethoxazole
Theophylline
Trimethoprim
study on Reflotron'* K+ .
their concentrations examined in the
Concentration
[mg/I]
I
1000
1000
300
100
30
200
200
100
20
200
10
100
1
10
20
100
18
100
200
40
100
1000
10
20
60
600
100
20
11
300
200
30
10
3
20
20
10
4
20
>1
10
0.1
1
2
10
2
20
20
4
20
200
2
2
6
60
10
2
menting plasma (containing 135 mmol/l sodium) with
sodium chloride. Interference was observed only
above 189 mmol/l sodium. Reflotron® K+ test results
are therefore unaffected by normal sodium concen-
trations, and are similarly unaffected by pathologi-
cally high or low concentrations.
Also, ammonium ions, in concentrations up to 20
times those found in plasma samples treated with
ammonium heparinate, were found to have no effect
on the recovery. This sample material can therefore
be used on Reflotrpn® K+.
The K+ recovery of the reagent carrier system in
dependence on the sample volume is shown in table
4. The indifference of the reagent carrier to the
amount of sample volume applied (28 to 32 μΐ are
allowed) ensures that reliable results are obtained even
when slightly varying sample volumes are applied by
inexperienced operators. Serious pipetting errors, i. e.
sample volumes differing by more than 10% from the
recommended volume, must be avoided.
The results of the drug interference study (tab. 5)
show that neither toxic nor therapeutic concentrations
of 28 commonly used drugs were found to have any
marked influence on the K+ recovery of Reflotron®
K+ (recovery 100 ± 5%).
30 rr
20 40 60 80 100 120
Protein concentration [g/l]
140 160
Fig. 8. Protein dependence of results of Reflotron^ K+ and the
ISE method (ISE 2020). The percentage differences be-
tween results obtained with FAES and those obtained
with Reflotron1» K+ (x) and the ISE method (o) are
plotted against the concentration of total protein [g/l]
as determined by the biuret reaction.
Ν = 39 sera
Reflotron® K+: y = -7.92 + 1.12x
ISE 2020: y = -11.2 + 1.68x
Eur. J. Clin. Chem. Clin. Biochem. / Vol. 31,1993 / No. 8
552 Paschen et al.: Determination of K+ by dry reagent carrier
Protein dependence
Figure 8 shows the protein dependence of potassium
determination with Reflotron® K+ and the ISE 2020
method relative to FAES.
Since Reflotron® K+ is calibrated using sera with a
normal protein content, it was to be expected that the
reagent carrier system and FAES would generate iden-
tical results for samples with protein concentrations
in the reference interval (60 — 75 g/1).
The results of the reagent carrier system, however,
differ by - 4.6% or + 5.5% from those obtained
with FAES when sera with high or low protein con-
tents (30 or 120 g/1) are used. The direct ISE 2020
method shows the same effect as Reflotron® K+, but
differs from FAES by - 6.2% and + 9%, so that its
protein dependence is somewhat higher. The results
of Reflotron® K"1" are therefore very similar to those
obtained with ion selective electrodes.
For the last 20 years it has been well known that the
results obtained with the ISE method for sodium and
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potassium reflect the clinical state of the patient with
abnormal protein or lipid concentrations far better
than FAES results, because FAES analyses the po-
tassium concentration irrespective the fact that the
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trolytes (13). Both the ISE method and Reflotron®
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